透析前低钠血症及透析期间血钠变化是血液透析患者死亡的显著预测因素
该研究基于日本全国登记数据库178,114例每周3次血液透析患者,分析透析前血钠浓度及透析期间血钠变化(ΔSNa)与2年全因死亡的关系。结果显示,透析前血钠每降低1 mEq/L,全因死亡风险增加5%(HR 1.05,95%CI 1.05-1.06);ΔSNa每增加1 mEq/L,死亡风险增加2%(HR 1.02,95%CI 1.01-1.02)。低透析前血钠合并大ΔSNa者死亡风险更高(HR 1.09,95%CI 1.05-1.13)。
要点
- 透析前血钠每降低1 mEq/L,全因死亡风险增加5%。
- 透析期间血钠每升高1 mEq/L,全因死亡风险增加2%。
- 透析前血钠≤136 mEq/L且ΔSNa>4 mEq/L者死亡风险最高。
核心结论
- 透析前血钠较低和透析期间血钠变化较大均与血液透析患者全因死亡风险增加独立相关。
研究设计与样本
- 基于日本全国终末期肾病登记数据库,纳入178,114例每周3次血液透析患者,随访2年,采用Cox比例风险模型分析。
主要发现
- 随访2年期间共25,928例患者死亡。
- 透析前血钠每降低1 mEq/L,全因死亡HR为1.05(95%CI 1.05-1.06)。
- 透析期间血钠每升高1 mEq/L,全因死亡HR为1.02(95%CI 1.01-1.02)。
- 低透析前血钠合并大ΔSNa的联合效应HR为1.09(95%CI 1.05-1.13)。
- 透析前血钠≤136 mEq/L且ΔSNa>4 mEq/L者死亡率高于透析前血钠137-140 mEq/L且ΔSNa≤2 mEq/L者。
关键数值与推荐
- 透析前血钠按五分位分类,最低组≤136 mEq/L,中间组137-140 mEq/L。
- ΔSNa最高组>4 mEq/L,最低组≤2 mEq/L。
临床怎么用
- 对血液透析患者应关注透析前血钠水平及透析期间血钠变化幅度,二者可作为死亡风险分层指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies have shown that hyponatremia is associated with greater mortality in hemodialysis (HD) patients. However, there have been few reports regarding the importance of the change in serum sodium (SNa) concentration (ΔSNa) during dialysis sessions. To investigate the relationships of pre-dialysis hyponatremia and ΔSNa during a dialysis session with mortality, we analyzed data from a national registry of Japanese patients with end-stage kidney disease. METHODS: We identified 178,114 patients in the database who were undergoing HD 3 times weekly. The study outcome was 2-year all-cause mortality, and the baseline SNa concentrations were categorized into quintiles. We evaluated the relationships of SNa concentration and ΔSNa with mortality using Cox proportional hazards models. RESULTS: During a 2-year follow-up period, 25,928 patients died. Each 1-mEq/l reduction in pre-HD SNa concentration was associated with a cumulatively greater risk of all-cause mortality (hazard ratio [HR], 1.05; 95% confidence interval [CI], 1.05-1.06). In contrast, a larger ΔSNa was associated with higher all-cause mortality (HR for a 1-mEq/l increase in ΔSNa, 1.02; 95% CI 1.01-1.02). The combination of low pre-HD SNa concentration and large ΔSNa was also associated with higher mortality (HR 1.09; 95% CI 1.05-1.13). Participants with the lowest SNa concentration (≤136 mEq/L) and the highest ΔSNa (>4 mEq/L) showed higher mortality than those with an intermediate pre-HD SNa concentration (137-140 mEq/L) and the lowest ΔSNa (≤2 mEq/L). CONCLUSIONS: Lower pre-HD SNa concentration and higher ΔSNa are associated with a greater risk of mortality in patients undergoing HD.
引用
- Fujisaki K, Joki N, Tanaka S, et al. Pre-dialysis Hyponatremia and Change in Serum Sodium Concentration During a Dialysis Session Are Significant Predictors of Mortality in Patients Undergoing Hemodialysis. Kidney Int Rep. 2020. PMID: 33615059. doi:10.1016/j.ekir.2020.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。